Are Now

The nomination period has come to an end for the 2021 Dr. Paul Janssen Award for Biomedical Research. Thank you for your interest in this prestigious honor and be sure to sign up for our email list to stay up to date!

Selection Process & Criteria

The Dr. Paul Janssen Award for Biomedical Research is presented annually. Each year, the nominations are reviewed and awardee(s) are chosen by a Selection Committee of six to eight distinguished and independent scientists. Committee deliberations are confidential and independent of Johnson & Johnson or other outside influences. The award is a citation and a prize of $200,000.

The Selection Committee will choose a scientist (or a group of scientists), in basic or clinical research, who:

  • Has made a significant contribution to research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Exhibits the standards of innovation, insight, and leadership that Dr. Paul exemplified during his career.
  • Provides a living example that the study of science and technology can enable or has the potential to enable extended, healthy, productive life.
  • Displays a set of ethical values consistent with the Johnson & Johnson Credo and those values that guide the company.

The award can be given to a clinical or basic research scientist or group of scientists in academia, government, industry, private research institution, medical, or clinical practice. It will typically recognize an individual scientist but can be shared in circumstances in which the contributions of multiple nominees are viewed as being of similar importance. Self-nominations will not be considered.

Selection Committee

Dr. Elaine Fuchs, Ph.D. DPJA Chairperson 2024
Jeffrey Gordon, M.D.
Ruth Lehmann, Ph.D.
Arthur Horwich, M.D.
Michael Hall, Ph.D.
James Allison, Ph. D.